Percutaneous Coronary Intervention Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention
Conditions: ECMO; High-risk PCI Interventions: Procedure: Standby cannulated ECMO; Procedure: Prophylactic ECMO Sponsors: Beijing Anzhen Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials

Drug-Coated Balloon in Native Chronic Total Occlusion Percutaneous Coronary Intervention
Conditions: Coronary Artery Disease; Total Occlusion of Coronary Artery Interventions: Device: Paclitaxel Drug-coated balloon Sponsors: National Institute of Cardiology, Warsaw, Poland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials

Left Main Percutaneous Coronary Intervention Registry in Istanbul Medipol University Hospital
Conditions: Coronary Artery Disease; Left Main Coronary Artery Disease Interventions: Device: Percutaneous coronary intervention Sponsors: Medipol University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials

Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention
Conditions: Coronary Artery Disease Interventions: Drug: Ticagrelor 60mg; Drug: Clopidogrel Sponsors: University of Florida; Scott R. MacKenzie Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials

Plan to Evaluate Early Endothelialization of a Polymer Free Sirolimus-eluting Coronary Stent System (VIVO ISARTM) Compared With Everolimus-eluting Durable Polymer Stent (XIENCE SkypointTM) in Patients Undergoing Percutaneous Coronary Intervention.
Conditions: Coronary Artery Disease Interventions: Device: VIVO ISAR DES implanted in the First lesion, XIENCE Skypoint DES implanted in the Second lesion; Device: XIENCE Skypoint DES implanted in the First lesion, VIVO ISAR DES implanted in the Second lesion Sponsors: Fundaci ón EPIC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials

The 5th Generation Tele-Robotic-Assisted Percutaneous Coronary Intervention: A First-in-Human Trial
Conditions: Coronary Artery Disease; Myocardial Ischemia; Cardiovascular Diseases; Coronary Disease; Arteriosclerosis Interventions: Device: 5G Tele-Robotic-Assisted PCI Sponsors: Yan ' an Affiliated Hospital of Kunming Medical University; Shanghai Zhongshan Hospital; Kunming Chenggong District People ' s Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials

Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention
Conditions: Coronary Artery Disease; Dyslipidemias; Primary Prevention Interventions: Drug: Combination drug group of Ezetimibe 10 mg/Rosuvastatin 5 mg; Drug: Mono drug group of Rosuvastatin 20 mg Sponsors: Saint Vincent ' s Hospital, Korea Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2023 Category: Research Source Type: clinical trials

Antiplatelet Therapy After Successful Percutaneous Coronary Intervention for Chronically Occluded Coronary Artery
Conditions: Chronic Total Occlusion Interventions: Procedure: Percutaneous coronary intervention; Drug: Short dual Aspirin/Clopidogrel therapy; Other: Long dual Aspirin/Clopidogrel therapy; Other: Follow-up visit at 1 month; Other: Follow-up visit at 6 months; Other: Follow-up visit at 12 months Sponsors: Assistance Publique Hopitaux De Marseille Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials

Pre-hospital pulse glucocorticoid therapy in patients with ST-segment elevation myocardial infarction transferred for primary percutaneous coronary intervention: a randomized controlled trial (PULSE-MI)
DiscussionWe hypothesize that pulse-dose methylprednisolone administrated in the pre-hospital setting decreases inflammation and thus reduces final infarct size in patients with STEMI treated with primary PCI.Trial registrationEU-CT number: 2022 –500762-10–00; Submitted May 5, 2022. ClinicalTrials.gov Identifier: NCT05462730; Submitted July 7, 2022, first posted July 18, 2022. (Source: Trials)
Source: Trials - December 15, 2023 Category: Research Source Type: clinical trials

Safety and Effectiveness of GENOSS DES in Patients With Multivessel Coronary Artery Disease
Conditions: Percutaneous Coronary Intervention; Multivessel Coronary Artery Disease Interventions: Device: Genoss DES Sponsors: Genoss Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials

Chronic Total Coronary Occlusion Treatment Results 6 Years After Bioresorbable Scaffold Implantation
Conditions: Angina Pectoris; Coronary Artery Disease; Occlusion, Coronary Interventions: Procedure: Percutaneous coronary intervention. Sponsors: Pauls Stradins Clinical University Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials

Relation of Laboratory Indices to Left Ventricular Thrombus Formation in Patients With Acute Anterior ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention or Thrombolytic Therapy
Conditions: Left Ventricular Thrombus Interventions: Other: Primary percutaneous coronary intervention or thrombolytic therapy Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials

Role of Novel Biomarkers Associated With In-stent Restenosis After Percutaneous Coronary Intervention
Conditions: In-stent Restenosis Interventions: Diagnostic Test: bone morphogenetic protein-2 (BMP-2) Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials

Precision PCI Registry
Conditions: Coronary Artery Disease; Percutaneous Coronary Intervention Interventions: Other: DNA sample collection Sponsors: University of Florida; University of North Carolina, Chapel Hill; National Heart, Lung, and Blood Institute (NHLBI); University of Maryland, Baltimore Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials

REgiStry-based Cardiovascular qUality improvEment Research
Conditions: Percutaneous Coronary Intervention; Heart Failure; Cardiometabolic Syndrome; Structural Heart Abnormality Interventions: Behavioral: Cardiac rehabilitation; Other: Active post-market surveillance of devices; Other: Multi-omics approach to precision medicine; Other: The prescription pattern analysis Sponsors: Peking University Third Hospital; Peking University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials